These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5232235)

  • 1. The development of drugs and the responsibilities involved.
    Weston JK
    Ann N Y Acad Sci; 1967 Mar; 141(1):24-34. PubMed ID: 5232235
    [No Abstract]   [Full Text] [Related]  

  • 2. Government responsibilities in the development of new drugs.
    Ruskin A
    Ann N Y Acad Sci; 1967 Mar; 141(1):35-8. PubMed ID: 5232247
    [No Abstract]   [Full Text] [Related]  

  • 3. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 4. Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017.
    Doshi P; Spence O; Kuzucan A; Powers JH
    JAMA Intern Med; 2019 May; 179(5):719-721. PubMed ID: 30830158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old drugs, new bottles, therapeutic advantage?
    Somberg JC
    Am J Ther; 2002; 9(4):273-4. PubMed ID: 12115014
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicity of new drugs.
    Lowinger P
    Science; 1968 Aug; 161(3842):632. PubMed ID: 5664503
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience in monitoring drug reactions in outpatients. The Kaiser-Permanente Drug Monitoring System.
    Friedman GD; Collen MF; Harris LE; Van Brunt EE; Davis LS
    JAMA; 1971 Aug; 217(5):567-72. PubMed ID: 5109088
    [No Abstract]   [Full Text] [Related]  

  • 8. The project leader for new drug development.
    Hull JH
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 2):131-4. PubMed ID: 3816575
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward Better-Quality Compounded Drugs - An Update from the FDA.
    Woodcock J; Dohm J
    N Engl J Med; 2017 Dec; 377(26):2509-2512. PubMed ID: 29281577
    [No Abstract]   [Full Text] [Related]  

  • 10. Plans to reduce drug risks examined.
    Young D
    Am J Health Syst Pharm; 2007 Aug; 64(15):1568, 1574, 1578. PubMed ID: 17646555
    [No Abstract]   [Full Text] [Related]  

  • 11. The current status of guidelines for clinical research from the viewpoint of the pharmaceutical industry.
    Dixon RB
    J Clin Pharmacol; 1977; 17(11-12):691-6. PubMed ID: 925189
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and Medical Devices: FDA Oversight.
    White RS;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-74. PubMed ID: 28252887
    [No Abstract]   [Full Text] [Related]  

  • 13. US FDA seeks more pharmaceutical industry cash.
    Zwillich T
    Lancet; 2007 Feb; 369(9559):357. PubMed ID: 17283497
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug risks and benefits poorly communicated, experts contend.
    Young D
    Am J Health Syst Pharm; 2006 Jul; 63(14):1312, 1314. PubMed ID: 16809749
    [No Abstract]   [Full Text] [Related]  

  • 15. "Assessment of Pressor Effects of Drugs"-A New US FDA Draft Guidance for Industry.
    Turner JR
    Ther Innov Regul Sci; 2018 Jul; 52(4):397-399. PubMed ID: 29996733
    [No Abstract]   [Full Text] [Related]  

  • 16. New DTCA Guidance--Enough to Empower Consumers?
    Robertson CT
    N Engl J Med; 2015 Sep; 373(12):1085-7. PubMed ID: 26287748
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs on the market.
    JAMA; 1970 Feb; 211(7):1177. PubMed ID: 5466970
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry promotion of unlabeled uses.
    Schwarz LR
    Am J Health Syst Pharm; 2008 May; 65(10):908-10. PubMed ID: 18463338
    [No Abstract]   [Full Text] [Related]  

  • 19. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical drugs-the good and the not so good: together, we can make it better.
    Campbell AW
    Altern Ther Health Med; 2014; 20(1):9-11. PubMed ID: 24445351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.